Applied Clinical Trials
Using strategic planning to address hurdles in biosimilar development programs from the outset.
Rodeina Challand
Advertisement
Articles by Rodeina Challand
Applied Clinical Trials
A number of top-selling biological products in key therapeutic areas such as cancer, diabetes, and rheumatoid arthritis have recently lost, or will soon lose, patent protection.
Advertisement
Latest Updated Articles
Operational Challenges for Biosimilar StudiesMarch 17th 2016
- Operational Challenges for Biosimilar Studies
October 1st 2016
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Moving Beyond Disappointing Pilots: Scaling Adoption of AI-Enablement in Drug Development
2
Clinical Site Readiness for Cell and Gene Therapies: Operational and Supply Chain Challenges as they Scale and as they Expand into the Community Care Setting
3
ACT Brief: Data Provenance and Device Strategy, Cell-Gene Therapy Site Readiness, and Data Harmonization Bottleneck
4
Beyond Compliance: Vivalink's Cecilia Xi, PhD, on Data Provenance and Sustainable Device Strategy in Clinical Trials
5